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Abstract
Seasonal changes in the neuroendocrine actions of gonadal steroid hormones are triggered by
fluctuations in daylength. The mechanisms responsible for photoperiodic influences upon the
feedback and behavioral effects of testosterone in Siberian hamsters are poorly understood. We
hypothesized that daylength regulates the expression of androgen receptor (AR) and/or steroid
receptor coactivator-1 (SRC-1) in specific forebrain regions. Hamsters were castrated and implanted
with either oil-filled capsules or low doses of testosterone; half of the animals remained in 16L/8D
and the rest were kept in 10L/14D for the ensuing 70 days. The number of AR-immunoreactive (ARir) cells was regulated by testosterone in medial amygdala and caudal arcuate, and by photoperiod
in the medial preoptic nucleus and the posterodorsal medial amygdala. A significant interaction
between photoperiod and androgen treatment was found in medial preoptic nucleus and posterodorsal
medial amygdala. The molecular weight and distribution of SRC-1 were similar to reports in other
rodent species, and short days reduced the number of SRC-1-ir cells in posteromedial bed nucleus
of the stria terminalis (BNST) and posterodorsal medial amygdala. A significant interaction between
androgen treatment and daylength in regulation of SRC-1-ir was found in anterior medial amygdala.
The present results indicate that daylength-induced fluctuations in SRC-1 and AR expression may
contribute to seasonally changing effects of testosterone.
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1. Introduction
Dramatic seasonal fluctuations of reproductive function characterize most mammals.
Daylength (photoperiod) provides the critical environmental signal which regulates
neuroendocrine function. Transfer of male hamsters to short daylengths precipitates drastic
reductions in gonadotropin secretion which trigger testicular regression. Reproductive function
is significantly suppressed within approximately 6 weeks, and reaches a nadir after about 12
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weeks of short days [13]. Two striking changes occur in neuroendocrine function upon
exposure to such inhibitory photoperiods. First, short days exert a “steroid-dependent” effect,
in which gonadal steroid hormones gain an increased capacity to suppress serum LH and FSH
concentrations [7,17,43,48,51] but become less potent as activators of mounting, intromission,
and ejaculation [27,37]. Such effects are monitored by challenging long- and short-day
castrates with various doses of exogenous testosterone and assessing serum gonadotropin
concentrations and sexual behavior. Second, “steroid-independent” changes occur, whereby
LH and FSH levels are suppressed by short-day exposure even in castrated hamsters which are
not given steroid replacement [7,43,51]. Furthermore, sexual behavior declines more rapidly
after the removal of androgen than in long-day hamsters [27,37].
Previous studies have investigated central mechanisms responsible for the effects of
photoperiod upon the negative feedback and behavioral effects of testosterone. To a lesser
extent, investigators have sought to explain the steroid-independent effects of daylength. Early
work provided inconsistent evidence for influences of photoperiod on the metabolism of
androgen, or upon the number and affinity of androgen receptors (AR) extracted from brain
and pituitary homogenates, and failed to localize any such effects [6,38,45]. More recently,
immunocytochemical techniques have been used to assess effects of daylength on the number
of cells expressing these steroid hormone receptors in particular brain regions. For example,
short days suppress the induction of progestin receptors by estrogen in the preoptic area and
hypothalamus of female Syrian hamsters [23]. Less systematic study has been devoted to the
possible influence of daylength on androgen receptors [53]. We recently reported a significant
effect of relatively short-term (11 day) exposure to short days on androgen receptor
immunostaining in specific regions of the bed nucleus of the stria terminalis and the arcuate
nucleus of Siberian hamsters [8]. While such changes in AR immunostaining may represent
important events in the initiation of reproductive responses to photoperiod, the effects upon
AR immunostaining of longer-term exposure to short days, which would be adequate to trigger
gonadal regression, have not been tested. One aim of the present study was to address this issue
by assessing AR at the time maximal reproductive suppression is reached.
Influences of photoperiod on steroid hormone action may not be restricted to changes in
expression of the cognate receptors. A variety of in vitro studies reveal that nuclear receptor
coactivators dramatically enhance the transcriptional activity of steroid receptors (for reviews,
see Refs. [12,24,41]). These nuclear receptor coactivators are thought to enhance steroiddependent gene transcription via a two-step mechanism [20] in which coactivators bridge the
steroid receptor complex with the basal transcription machinery and remodel chromatin
structure through their intrinsic histone acetyltransferase activity [5,44]. Steroid receptor
coactivator-1 (SRC-1, also known as NCoA-1) was the first coactivator of steroid receptors to
be discovered and belongs to a larger p160 family of nuclear receptor coactivators [35]. This
family of coactivators also includes SRC-2 (NCoA-2/GRIP-1/TIF-2) [14,52] and SRC-3
(RAC3/AIB1/pCIP/ACTR/TRAM1; 119, [1,19,47]). SRC-1 enhances the transcriptional
activity of steroid receptors, including AR, ER and PR, in a ligand-dependent manner in vitro
[34]. SRC-1 is expressed in a variety of hormone-responsive tissues including brain, uterus,
prostate, and breast (for review, see Ref. [31]). In brain, SRC-1 is expressed in many regions
in which gonadal steroids act to regulate gonadotropin secretion and behavior (for review, see
Refs. [31,49]). In addition, studies suggest that expression of nuclear receptor coactivators in
brain is regulated by hormones [4,9,15,28]. Moreover, functional studies reveal that SRC-1
modulates steroid-dependent brain development [3,33], gene transcription in brain, and the
expression of reproductive behavior [2,30]. Despite their potentially pivotal influence, the
hypothesis that daylength regulates steroid hormone action through an influence on SRC-1
expression has not been tested in a species which breeds seasonally. In hamsters, light-regulated
expression of pCREB-binding cofactors p300 and CBP have been examined only in the
suprachiasmatic nucleus and in the context of circadian rhythms [11]; the role of steroid

response cofactors in photoperiodic responses has not been investigated. Thus, in the present
studies, we sought to quantify effects of androgen and daylength on SRC-1 expression in
neuroendocrine regions of the Siberian hamster brain.

2. Methods
All procedures were approved by the University of Massachusetts IACUC and conformed to
the NIH Guidelines for Animal Care and Use. Thirty-four young adult male Siberian hamsters
(Phodopus sungorus, age 5-11 weeks), born and raised in 16L/8D (lights on 04:15), were
castrated under sodium pentobarbital anesthesia (60 mg/kg) and immediately implanted with
subcutaneous Silastic capsules (0.145 cm i.d., 0.193 cm o.d.) containing either sesame oil or
12.5 mg/ml testosterone in sesame oil (Sigma, St. Louis, MO) as previously described [8].
Acetominophen was added to the drinking water to insure post-operative analgesia. Half of the
animals given each type of capsule were transferred to 10L/14D immediately after surgery.
After a survival period of 70 days, hamsters were anesthetized with sodium pentobarbital (100
mg/kg). The thoracic cavity was opened, a blood sample was taken, and the animal was
heparinized (500 U, Rugby laboratories) and transcardially perfused with 0.1 M phosphate
buffer (pH 7.4) followed by 5% acrolein containing 0.25% glutaraldehyde in phosphate buffer.
The brains were removed and post-fixed for 4 h before infiltration with 30% sucrose in 0.1 M
phosphate buffer. Sections were cut at a thickness of 40 μm on a rotary microtome. A 1-in-6
series was collected into cryoprotectant and stored at -20 °C until the time of immunostaining.
The small size of the Siberian hamster and the choice of 40-μm section thickness made it
impossible to focus on all subregions of the BNST and the arcuate nucleus of individual animals
when analyzing both AR-ir and SRC-1ir in the same brain. Our previous study [8] indicated
the importance of carefully examining AR-ir across the rostral-caudal extent of the arcuate
nucleus. We elected to examine immunostaining in both anterior and posterior BNST in our
study of SRC-1 ir, but could only analyze one intermediate plane of the BNST when analyzing
AR-ir.
Serum was harvested and frozen at -20 °C until radioimmunoassays were performed. LH was
measured in a single assay whose sensitivity was 1.21 pg/tube. Testosterone was extracted
from 50 μl aliquots of serum using 1.2 ml of diethyl ether (Burdick-Jackson), evaporated, and
assayed using GDN#250 as antibody (1:50,000) and (1,2,6,7,16,17-[3H])-T as trace (NET553,
New England Nuclear).
2.1. Western blot analysis
In order to characterize SRC-1 immunoreactive peptide in Siberian hamster brain, Western
blots were performed on tissue extracts obtained from additional long-day hamsters.
Immediately following decapitation, hypothalamic brain tissue was excised, placed in chilled
microfuge tubes, snap frozen on dry ice and stored at -80 °C. Tissue was homogenized in TEDG
(consisting of 10 mM Tris-base, pH=7.4, 1 mM EDTA, 1 mM Dithiothreitol (DTT), 10%
glycerol) containing 400 mM NaCl and protease inhibitors (1 μg/ml of aprotinin, leupeptin,
and pepstatin) using a Teflon homogenizer. After tissue homogenization, samples were
centrifuged at 12,000×g for 30 min at 4°C to sediment cellular debris and nuclei. The
supernatant fraction was collected, and the protein concentration was determined by Bradford
assay. Eighty micrograms of total protein from each tissue sample was gel electrophoresed on
7.5% polyacrylamide gels containing 1% SDS and transferred to a polyvinylidene difluoride
membrane (Millipore, Bedford, MA). The membrane was washed briefly in TBS-T (12 mM
Tris, 180 mM NaCl, 0.06% Tween 20, pH=7.4) and then incubated for 1 h in TBS-T containing
5% nonfat dry milk with constant agitation to block nonspecific binding. The membrane was
then incubated with 1135/H4, a mouse monoclonal antibody generated against amino acids
477-947 of human SRC-1 (0.05 μg/ml, kindly provided by D. Edwards, University of Colorado

HSC and B. O'Malley, M. Tsai and S. Onate, Baylor College of Medicine) overnight in TBST containing 0.02% NaN3 at 4 C. After washes in TBS-T, the membrane was incubated in a
sheep anti-mouse horseradish peroxidase-linked secondary antibody (Amer-sham, Sweden),
diluted at 1:6000 in TBS-T, for 1 h at room temperature with agitation. Following washes in
TBS-T, immunoreactive bands were detected with an enhanced chemiluminescence kit
(ECLPlus, Amersham), followed by exposing the membrane to Biomax film (Kodak Film,
NY). Recombinant human SRC-1 protein, extracted from Sf9 insect cells (Tissue Culture
CORE Facility of the University of Colorado Cancer Center) infected with the appropriate
recombinant transfer plasmids as described previously [50], was used as a positive control for
Western blots.
2.2. Immunohistochemistry
Immunocytochemical detection of AR was performed as described previously [8]. Sections
were initially rinsed in 0.05 M Tris-buffered saline (TBS), followed by a pretreatment of 1%
sodium borohydride for 10 min to remove residual aldehydes. Tissue was then rinsed in TBS
and incubated in a solution of 1% H2O2, 20% normal goat serum and 1% bovine serum albumin
in TBS for 20 min to decrease nonspecific staining and reduce endogenous peroxidase activity.
Sections were rinsed in 0.05 M TBS, and incubated overnight in rabbit anti-AR (PG-21,
generously supplied by Dr. Geoffrey Greene, Ben May Institute, Chicago, IL) at 1:1000. After
thorough rinsing, sections were incubated in biotinylated goat anti-rabbit (1:500, Vector
Laboratories, Burlingame, CA) followed by avidin-biotin peroxidase (Vector).
Immunostaining was visualized by incubation in 5 μM nickel ammonium sulfate, 2 M sodium
acetate, 49 mM ammonium chloride, 0.3% benzi-dine in TBS. After rinsing in TBS, sections
were mounted onto slides, dried, and coverslipped with Permount.
For detection of SRC-1, sections were incubated for 48 h in the SRC-1 monoclonal antibody,
1135/H4 (1 μg/ml), in TBS containing 0.02% sodium azide (NaN3), 1% normal goat serum,
0.1% gelatin and Triton-X (pH 7.6 at 4 °C). Tissue was rinsed in TBS containing NaN3, gelatin
and Triton-X prior to incubation in a biotinylated goat anti-mouse IgG (3 μg/ml, Jackson
Laboratory, West Grove, PA) in TBS containing NaN3 and Triton X-100 and 1.5% normal
goat serum for 90 min. Tissue was rinsed in TBS containing NaN3, gelatin and Triton X-100
followed by rinsing in TBS. Sections were then incubated for 90 min in TBS containing 1%
avidin DH: biotinylated horseradish peroxidase H complex (Vectastain ABC Elite Kit, Vector)
followed by rinsing in TBS. Finally, sections were exposed to 0.5% diaminobenzine (DAB)
with 3% hydrogen peroxide with TBS for approximately 3 min. The sections were rinsed in
TBS and then mounted on microscope slides and coverslipped.
2.3. Quantification of immunostaining
In order to quantify AR- or SRC-1 immunostained cells, relevant brain areas were inspected
at 200× magnification on a Zeiss Axioscope. The observer was blind to the experimental
treatment of the animals. Images were captured using an MTI CCD72 camera and an Apple
Power Macintosh 7100 computer. The NIH Image program was utilized to count the number
of cells stained to densities 3 or more standard deviations above background as previously
described [7]. Validation experiments employing linear regression verified that application of
this criterion resulted in numbers of cells which correlated well with the number estimated by
eye (r2=0.92).
Matched sections from long and short-day hamsters were processed simultaneously in order
to quantify AR and SRC-1 immunostaining (AR-ir and SRC-1ir) in brain regions which
participate in feedback and behavioral effects of testosterone. We quantified SRC-1-ir in the
portions corresponding to the anteromedial and posteromedial bed nucleus of the stria
terminalis (BNST) as described by Ju and Swanson [16], and we counted AR-ir cells in an

intermediate plane of the BNST. Both AR- and SRC-1-immunoreactivity were also quantified
in the anterior and posterior portions of the medial amygdaloid nucleus, the medial preoptic
nucleus, and in the rostral, middle and caudal portions of the arcuate nuclei. Since no published
atlas of the Siberian hamster brain is available, the rat brain atlas of Paxinos and Watson [36]
(plates 26-28, 29-32, and 33-36, respectively) and the Syrian hamster atlas of Morin and Wood
[32] were used to identify relevant areas; for a schematic depiction of brain regions analyzed,
see Fig. 1.In general, immunostained cells of each hamster were counted in a single focal plane
of two non-consecutive sections of the 1-in-6 series containing the same anatomical region. A
standard shape (square or oval as illustrated in Fig. 1) fitting the approximate dimensions of
the region of interest was applied to each section for purposes of quantification; the length of
the side or the major axis of the shape varied between nuclei but was approximately 125-175
μm.
Data were analyzed by ANOVA for the main effects of androgen treatment and photoperiod,
and their interaction as described previously [8]. The Student-Newman-Keuls test was used
for post-hoc comparisons. Differences were considered significant at p<0.05.

3. Results
3.1. Body weight
Hamsters did not differ in body weight at the time of their assignment to different groups.
ANOVA indicated significant main effects of photoperiod on body weight (p=0.001): after 10
weeks, castrated short-day hamsters were lighter than those held in long days (28.7±1.1 vs.
35.1±1.5, mean±S.E.M.; p=0.003). A similar trend did not achieve statistical significance in
steroid-implanted castrates (28.8±0.9 g vs. 31.5±1.3 vs. in short vs. long-day hamsters,
respectively). Low-dose androgen replacement had no significant effect on final body weight
in either photoperiod (28.7±1.1 vs. 28.8±0.9 g in short days, and 35.1±1.5 vs. 31.5±1.3 g in
long days in castrated vs. androgen-treated hamsters, respectively; pN0.1). Thus, short-day
exposure precipitated a 17% decline in body weight in both T-treated castrates and oil-treated
control hamsters (6.2±1.7 and 6.0±0.8 g, respectively). There was no interaction between
daylength and T treatment.
3.2. Hormone concentrations
Serum androgen concentrations were generally undetectable in castrated hamsters which
received oil capsules. In hamsters implanted with T capsules and perfused 70 days after capsule
implantation, serum testosterone values were near the limits of detection, averaging 20.3±5.2
pg/ml. This value is approximately 10% of that found in intact long-day Siberian hamsters in
the same assay.
Analysis of variance indicated a significant influence of photoperiod upon serum LH
concentrations (p<0.01). Short-day exposure significantly reduced serum LH concentrations
in hamsters given either oil or 12.5 mg/ml capsules (p<0.05 and p<0.001, respectively).
However, this dose of testosterone did not influence LH values (p=0.55), and there was no
significant interaction between photo-period and androgen dose (p=0.56).
3.3. AR immunostaining
No significant effects of either photoperiod or testosterone treatment on the number of AR-ir
cells were evident in the BNST of hamsters killed 70 days after the implantation of blank or
testosterone capsules (Fig. 2; Table 1). Furthermore, there was no interaction between
photoperiod and testosterone treatment. In the MPN, photoperiod exerted a significant main
effect (p=0.002) but testosterone treatment did not, and there was an interaction between these
factors (p<0.005; Fig. 3). This may be explained by the significant suppression of AR staining

by short days in blank-implanted castrates (p<0.02), whereas short days tended to increase AR
staining in animals receiving testosterone (p=0.07).
In neither the anterior nor the posterior nuclei of the medial amygdala was the effect of
photoperiod statistically significant (p=0.08 and 0.47, respectively; Table 1). Testosterone
treatment exerted significant effects in both portions of the amygdala (p<0.005), and the
interaction between photoperiod and androgen was statistically significant in the posterodorsal
(p<0.01), but not the anteromedial amygdala (0.05<p<0.10). This interaction may result from
a short-day-induced reduction in the number of AR-ir cells in animals which received T
capsules (p<0.02), but not in blank-implanted castrates (p=0.15). Furthermore, low-dose
androgen replacement reduced the number of AR-ir cells in the anterior medial amygdala of
short-day animals (p=0.001) but had only a marginal effect in long-day hamsters (p=0.05).
Photoperiod was without significant effect upon AR-ir staining in any portion of the arcuate
nucleus, and there was no interaction between photoperiod and low-dose androgen replacement
in this region (Table 1). Low-dose androgen replacement was without significant effect in
either the rostral or middle arcuate, but there was a significant effect of androgen treatment on
the number of AR-ir cells in the caudal arcuate (p<0.05). This was apparently due to a decrease
in the number of AR-ir cells in the caudal arcuate upon androgen treatment in long-day hamsters
(p<0.04); there was no such effect in short-day animals (p=0.4).
3.4. SRC-1 immunostaining
Analysis by Western blot using the SRC-1 monoclonal antibody, 1135/H4, revealed that SRC-1
protein is expressed in the hypothalamus of Siberian hamsters (Fig. 4) at a molecular mass of
160 kDa, which is similar to reports from other species [46]. SRC-1 immunoreactivity was
observed in many brain regions, including particularly high levels of expression in the
hippocampus, cortex, amygdala, preoptic area and hypothalamus (Fig. 2). This expression
pattern of SRC-1 protein is consistent with reports of SRC-1 mRNA and protein expression in
rat [15,25,30] and mouse [22,29,33,42] brain. Taken together with our Western blot data, these
findings indicate that SRC-1 protein is expressed in brain regions known to regulate
reproductive functions in hamsters.
Photoperiod exerted a significant effect on the number of SRC-1-ir cells in the posteromedial
BNST (p<0.05; Table 2; Fig. 5). The short-day induced reduction in SRC-1 immunostaining
was evident in both castrated and T-treated hamsters, but there were neither significant effects
of low-dose androgen replacement nor an interaction between T condition and photoperiod. In
contrast, photoperiod and androgen were without significant effect in the anterior BNST, and
these factors did not interact to regulate the number of SRC-1-ir cells.
In the anteromedial amygdala, overall ANOVA the number of SRC-1-ir cells was not affected
by photoperiod or T (Table 2). Nevertheless, ANOVA indicated a significant interaction
between photoperiod and androgen treatment (p<0.03). In the posterodorsal medial amygdala,
photoperiod exerted a significant effect on SRC-1-ir cells (p<0.05), which arose from an effect
of daylength on castrated animals (p=0.05). There was no significant effect of androgen
treatment and no interaction between hormonal condition and photoperiod.
In neither the medial preoptic nucleus nor arcuate nucleus was the number of SRC-1-ir cells
affected by photoperiod or androgen treatment (p>0.10), although there was a trend towards a
reduction in the number of immunostained cells in the MPN of short-day castrates (p=0.07).
There was no interaction between photoperiod and low-dose androgen treatment.

4. Discussion
The present results indicate that photoperiodic regulation of body weight, gonadotropin
secretion, and male sexual behavior may be accompanied by changes in androgen receptor and
SRC-1 expression in specific regions of hamster brain. These changes may contribute to
seasonal fluctuations in the response to gonadal steroids and/or steroid-independent effects of
daylength.
Despite its dramatic response to photoperiod and popularity as a subject for studies of seasonal
reproduction, few studies have addressed androgen receptor expression in the Siberian hamster.
Our previous work concentrated on initial responses to short-day exposure at survival intervals
that precede gonadal regression [8]. Although photoperiod effects upon numbers of AR-ir cells
were restricted to the middle arcuate, effects of androgen were evident in all regions of the
neuroendocrine forebrain. At this survival time, photoperiod and androgen were found to
interact in the regulation of AR-ir in the BNST, medial amygdala and arcuate. It was not clear
in that experiment, however, whether more dramatic changes in AR-ir might take place as the
nadir of reproductive function approaches. In the current study, therefore, we focused on ARir in animals that had experienced 10 weeks of short-day exposure, which is adequate to
precipitate the full gonadal response in intact animals. We found no dramatic differences in
the effects of photoperiod on AR-ir at the short and long survival times. After 70 days of lowdose androgen replacement, the main effects of testosterone achieved statistical significance
in the medial amygdala and the caudal arcuate nucleus. The main effects of photoperiod upon
AR-ir, which were few in our previous study, were non-significant in each of the
neuroendocrine regions we examined in hamsters allowed to survive for 10 weeks. As we found
at 11 days of short-day exposure, interactions between photoperiod and androgen occur in
several regions. At 10 weeks, such interactions were found in the MPN and posteromedial
amygdala. Thus, the influence of testosterone and daylength on AR-ir expression in these
regions is largely consistent at these two survival times, and interactions between photoperiod
and androgen are also generally evident. The relatively minor discrepancies may reflect the
transient nature of photoperiodic responses; hamsters which have experienced 10 weeks of
inhibitory photoperiods are preparing for gonadal recrudescence and refractoriness to short
days and this may explain some of the differences from the patterns of AR-ir in animals
beginning to experience the effects of winter photoperiods at 11 days. Furthermore, although
both studies utilized low doses of androgen, the testosterone-implanted hamsters in the present
studies had particularly low serum testosterone concentrations. This most likely reflects
exhaustion of the Silastic capsules after many weeks. Although short days clearly influenced
LH secretion and body weight, the levels of testosterone were probably too low to trigger the
differential feedback response reported in earlier studies [7,43] and thus may have led us to
underestimate the potential for photoperiod effects on AR-ir and interactions between
daylength and testosterone. Further experimentation utilizing a wider range of androgen doses
and survival times is warranted in order to characterize fully the influence of photoperiod and
testosterone on androgen receptor expression.
In recent years, it has become clear that nuclear receptor coactivators are essential to the
influences of gonadal hormones on their target cells [31,49]. To our knowledge, the present
study is the first to explore the possibility that photoperiod modulates expression of these
coactivators. Short photoperiod significantly reduced the number of SRC-1-ir cells in the
posteromedial BNST and tended to reduce staining in the MPN. This effect may contribute to
the reduction in the ability of androgen to activate male sexual behavior in short-day hamsters
[27,37]. Furthermore, lesion studies indicate the BNST in photoperiodic regulation of
reproduction in Syrian hamsters [39,40]; photoperiodic and androgen influences on AR-ir and
SRC-1-ir in this region may thus represent a mechanism important in seasonal reproduction.
The influence of photoperiod and androgen on AR-ir and SRC-1-ir in the posteromedial

amygdala may also contribute photoperiodic regulation of testosteroneregulated sexual
behavior, and help to explain the photoperiod-dependent remodeling of this brain region
described by Cooke et al. [10].
In light of previous reports that gonadal steroid hormones can regulate SRC-1 expression, we
were surprised not to find significant effects of T treatment on SRC-ir in the present study.
This may be related to the low-dose of androgen administered. There was evidence for
regionally restricted interactions between daylength and androgen. The observation that
photoperiod can modulate SRC-1 expression in the BNST of castrated hamsters may be
particularly relevant to the steroid-independent effect of daylength, particularly in light of the
possibility that unliganded steroid receptors may interact with SRC-1 or other cofactors in
order to regulate gene expression.
It would be worthwhile to determine whether SRC-1 ir is particularly affected by androgen
treatment and/or photoperiod in cells that express gonadal steroid hormone receptors. Such
double-label studies might provide evidence of a physiologically significant interaction that is
not evident when all SRC-1 ir cells are surveyed in single label experiments such as the present
study. It is also possible that quantitatively minor changes in SRC-1 and AR expression which
result from fluctuations in photoperiod and/or androgen levels exert a multiplicative influence
on feedback or behavioral responses to testosterone. The changes in SRC-1-ir seen in this study
must again be interpreted keeping in mind the low doses of testosterone employed and the
relatively long survival time. As is the case for AR-ir staining, exploration of changes in SRC-1
expression across a wider range of androgen treatments and survival times is needed. It is
essential to better our understanding of the mechanisms by which photoperiodic effects
influence neuronal responsiveness to steroid hormones. Our present findings suggest that
regulation of nuclear receptor coactivators may be an important event in this fine-tuning of
neuronal responsiveness specific brain regions. Thus, the possibility of changes in other nuclear
receptor coactivators (e.g., SRC-2, SRC-3...) upon photoperiodic challenges and steroid
hormone treatment deserves further exploration. Such studies may pave the way for
examination of effects of manipulation of coactivator protein expression (e.g. Refs. [3,30,
41]) on gonadal responses to photoperiod.
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Fig. 1.

Schematic illustration of coronal sections of Siberian hamster brain. Crosshatching indicates
regions in which AR-ir and SRC-ir were quantified. BNST, bed nucleus of the stria terminalis;
MPN, medial preoptic nucleus; MeA, anteromedial amygdala; MePD, posterodorsal
amygdala; rARC, rostral arcuate nucleus; mARC, middle arcuate nucleus; cARC, caudal
arcuate nucleus. Modified after Morin and Wood [32].

Fig. 2.

Representative photomicrographs illustrating AR-ir cells (top) and SRC-1-ir cells (bottom) in
the BNST. SD, sections from hamsters exposed to 10L/14D for 10 weeks prior to sacrifice;
LD, hamsters exposed to 16L/8D. Scale bar in top left panel (applies to all micrographs), 40
μm.

Fig. 3.

Effects of testosterone (T capsules) and photoperiod on AR-ir in BNST (top) and MPN
(bottom) of Siberian hamsters after 70 days of treatment. Bars represent mean±S.E.M. number
of immunoreactive cells. Hamsters were maintained in 16L/8D (long days, open bars) or 10L/
14D (short days, shaded bars) after castration. Asterisk indicates significant suppression of AR
staining in short-day, oil-treated castrates (p<.02).

Fig. 4.

SRC-1 is expressed in Siberian hamster brain. Western blot analysis shows SRC-1 expressed
at 160 kDa in the male hamster hypothalamus.

Fig. 5.

Effects of testosterone and photoperiod on number of SRC-1 immunoreactive cells in Siberian
hamster BNST. In the posteromedial BNST, short days reduced SRC-1-ir (p<0.02, asterisk).
Legends as in Fig. 3.

Table 1

Effects of photoperiod and androgen treatment on number of cells immunostained for androgen receptor in Siberian
hamsters
Long days

Short days

Castrate

Castrate+T

Castrate

Castrate+T

BNST

87.3±21.6

90.0±14.4

84.0±14.3

54.3±11.1

MeA

47.0±3.4*

39.3±3.6**

48.3±8.8*

20.0±5.3

MePD

32.0±4.7

30.1±3.9**

46.2±4.7*

20.0±3.4

MPN

95.7±43.7**,*

35.8±5.6

44.0±13.8

89.1±18.1

rARC

51.0±7.0

46.5±5.6

42.8±6.3

48.9±6.3

mARC

81.5±4.2

64.0±7.8

63.2±9.1

70.1±7.9

cARC

98.3±12.1*

70.5±4.3

98.4±12.2

86.1±8.7

*

p≤0.05 vs. corresponding T-treated group.

**

p≤0.05 vs. corresponding SD group.

Table 2

Effects of photoperiod and androgen treatment on number of cells immunostained for steroid receptor coactivator-1
(SRC-1) in Siberian hamsters
Long days

Short days

BNSTa

Castrate

Castrate+T

Castrate

Castrate+T

89.5±5.6

88.6±3.0

87.7±4.0

89.4±5.9

95.2±3.8*

95.7±3.4

77.2±6.0

83.5±7.7

81.0±2.9*, **

71.0±2.8

71.8±3.4

75.9±2.7

109.3±2.9*

108.0±2.9

98.5±4.2

103.1±4.0

MPN

99.2±4.2

95.9±2.6

88.5±3.3

93.6±4.8

mARC

81.0±3.8

81.5±5.2

83.3±4.7

83.4±0.7

BNSTpm
MeA
MePD

*

p≤0.05 vs. corresponding SD group.

**

p≤0.05 vs. corresponding T-treated group.

